(MedPage Today) — In the search for shorter, effective, and safe regimens to treat fluoroquinolone-susceptible, rifampin-resistant tuberculosis (TB), three 9-month regimens incorporating newer and repurposed drugs proved on par with standard 18…
Source link : https://www.medpagetoday.com/pulmonology/tuberculosis/113999
Author :
Publish date : 2025-01-29 22:00:00
Copyright for syndicated content belongs to the linked Source.
